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Dobutamine Stress Echo For Myocardial Viability 
Assessment
Ignatius Yansen, Amiliana Mardiani, Ario Soeryo Kuncoro
The prevalence of left ventricular (LV) dysfunction and resultant heart 
failure is increasing in developing countries. Two thirds of cases of left 
ventricular dysfunction are the result of coronary artery disease (CAD). 
Although there have been significant advances in medical therapy for LV 
dysfunction and resulting symptoms of heart failure, the prognosis from 
heart failure remains extremely poor. Many of these patients had previous 
myocardial infarctions, the extent of remaining viable tissue is of clinical 
interest, and also related to prognosis. Thus assessing myocardial viability 
is very important in patient with left verntricuar dysfunction to choose the 
right management. Dobutamine stress echo is one of the most common 
tool that used to asses myocardial viability.
A 67 years old patient with chronic heart failure because of old anterior 
and inferior MCI with low ejection fraction. It is very important to assess 
the viability in patients with advanced heart failure to know the future 
management because it is related to patient’s morbidity and mortality. 
With little viable myocard in this patient, the best management for this 
patient is conservative therapy with medical therapy. Dobutamine stress 
echocardiography therefore, may well provide complementary information 
in the assessment of myocardial viability. Future modalities are now being 
studied to give more objective measurement of myocardial viability with 
higher sensitivity and specificity.
(J Kardiol Indones. 2011;32:96-106)
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The prevalence of left ventricular (LV) dysfunction 
and resultant heart failure is increasing in developing 
countries. Two thirds of cases of left ventricular 
dysfunction are the result of coronary artery disease 
(CAD). 1 Not only are these patients at high risk 
for subsequent cardiac death, severe morbidities, 
and recurrent hospitalizations for congestive heart 
failure, they also frequently have severe limitations in 
Prevalensi dari disfungsi ventrikel kiri dan kejadian gagal jantung meningkat dalam negara berkembang. Dua pertiga dari kasus 
disfungsi ventrikel diakibatan oleh penyakit arteri koroner. Walaupun dengan adanya kemajuan terapi medis yang signifikan 
untuk disfungsi ventrikel kiri dan gejala gagal jantung, prognosis gagal jantung tetap buruk. Banyak dari pasien- pasien ini 
pernah mengalami infark miokard sebelumnya, adanya jaringan yang masih viable menjadi pusat perhatian karena terkait 
dengan prognosis. Dengan demikian penilaian viabilitas miokard sangat penting pada pasien dengan disfungsi ventrikel untuk 
memilih terapi yang tepat. Dobutamine stress echo adalah salah satu modalitas yang dapat digunakan untuk menilai viabilitas 
miokard.  
Seorang pasien usia 67 tahun dengan gagal jantung kronik yang diakibatkan oleh infark miokard anterior dan inferior dengan 
fraksi ejeksi yang rendah. Sangat penting untuk melakuan penilaian terhadap viabilitas miokard pada pasien dengan gagal 
jantung lanjut untuk mengetahui managemen selanjutnya karena terkait dengan morbiditas dan mortalitas. Dengan hanya 
sedikit miokard yang masih viable maka terapi yang terbaik pada pasien ini adalah dengan terapi konservatif berupa terapi 
medis. Dengan demikian dobutamine stress echo dapat memberian informasi tambahan untuk managemen lanjutan dari 
pasien. Saat ini sedang dikembangkan modalitas untuk memberikan penilaian objektif tentang viabilitas miokard dengan 
sensitifitas dan spesifisitas yang lebih baik.
(J Kardiol Indones. 2011;32:96-106)
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their lifestyles and well-being. Although there have 
been significant advances in medical therapy for LV 
dysfunction and resulting symptoms of heart failure, 
the prognosis from heart failure remains extremely 
poor. Many of these patients had previous myocardial 
infarctions, the extent of remaining viable tissue is of 
clinical interest, and also related to prognosis.1 
The need for making the diagnosis of resting 
ischemia, hibernation, or stunning stems from their 
role in exacerbating LV dysfunction, heart failure 
symptoms sudden death, hemodynamic deterioration 
and from the need to decide between revascularization 
and medical therapy. Several clinical studies have 
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shown that myocardial dysfunction in patients with 
CAD may be reversible.2 After an initial ischemic 
injury, various processes can occur that lead to LV 
dysfunction, including LV remodeling, impairment 
of energetics, myocyte dysfunction, and cell death via 
necrosis and/or apoptosis. Other than cell death, these 
processes are, to an extent, reversible, and LV function 
often can be improved, resulting in better patient 
outcome. Although medical therapy can be extremely 
beneficial, revascularization in the appropriate patient 
often is the best therapy. Left ventricular dysfunction, 
in some cases, is the result of ‘’stunned myocardium,’’ 
which is defined as myocardium that has become 
dysfunctional because of a transient coronary occlusion, 
has been salvaged by coronary reperfusion, yet exhibits 
prolonged but transient postischemic dysfunction, 
lasting hours to weeks. Thus, in myocardial stunning, 
blood flow has been restored but contraction has not 
returned to baseline thus there is a flow-contraction 
mismatch. Left ventricular dysfunction, in other cases, 
is the result of hibernating myocardium. This term  is 
refer to persistent LV dysfunction in the presence of 
severe CAD that is reversible after revascularization. 
The pathophysiology underlying these phenomena is 
thought to reflect the down-regulation of function in 
the presence of reduced blood flow and oxygen supply.3 
By this definition, hibernating myocardium is a flow-
contraction match. Regardless of the mechanism, 
it is important to identify hibernating myocardium 
because ventricular function will generally improve 
after revascularization or other therapies.
Objective
The aim of this presentation is to present a case of 
advanced heart failure and the role of dobutamine 
stress echo in assessing myocardial viability.
Case Illustration
Mr. GP, 67 years old is a patient of National Cardiac 
and Vascular Center of Harapan Kita. He was diagnosed 
having chronic heart failure because of old anterior 
inferior MCI with low ejection fraction. He complains 
of having dyspnea on effort with moderate activities 
like walking 100 m or climbing up the stairs. From the 
physical examination we cannot hear any murmurs or 
gallop. The electrocardiographic in out patient clinic 
reveals as sinus rhytm, with QRS rate 99x/ minute, 
QRS axis -30 degree, normal P wave, PR interval 0,18”, 
no ST changes, T inverted in lead I and aVL with Q 
pathologic in lead II, III, aVF, V1-V6 (Figure 1).  
Chest x-ray shows CTR 60%, with dilated and 
calcified aortic segment, normal pulmonic segment, 
Figure 1. 12-lead electrocardiogram
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Perfusion scanning showed fixed defect in anterior 
apical and apex (non viable), partial reversible defect 
in septum and inferior (viable) with stress LVEF 17% 
and rest LVEF 25% (Figure 4). With these results 
then the patient is managed with medical therapy only 
(conservative).  
Literature Review And Discussion
Myocardial viability
Assessment of myocardial viability is of critical 
importance for the management of patients with 
chronic coronary artery disease and reduced left 
ventricular function. Asynergic but viable myocardium 
has been assumed to improve its systolic function after 
revascularization, whereas nonviable segments do not. 
Thus, patients with a large portion of dysfunctional 
but viable myocardium are believed to benefit from 
revascularization.4 In addition, revascularization of 
viable myocardium may be beneficial by preventing 
remodeling and electrical instability. Figure 5 
showed the death rates for patients with and without 
myocardial viability treated by revascularization or 
medical therapy.
flattening cardiac waist, apex lateral downward. Then he 
underwent cardiac catheterisarion in Decemer 2009 and 
showed CAD 3VD : LM normal, LAD 95% stenotic 
after D1, 80-90% stenotic from mid to distal, LCX 
tandem stenotic 80% before OM1 and 80% stenotic 
at distal part, RCA proximal total occlution. The 
echocardiography shows EDD 58  ESD 52, reduced LV 
systolic function EF 25%, akinetic apicoseptal, apical, 
midseptal and hypokinetic other segment, diastolic 
dysfunction restrictive, TR mild, PH mild, reduced RV 
contractility TAPSE 1,3 cm with SEC (+) in LV. He is 
considered to undergo revascularisation by CABG. Before 
having CABG, he underwent viability study by using 
Dobutamine stress echo and TC-99 Sestamibi myocardial 
perfusion scanning in February 2010. Dobutamine stress 
echo showed viable myocardium of basal segments of left 
ventricle, the rest of the LV were non viable (Figure 2).
In this patient tissue perfusion imaging was done 
to assess the viability of the left ventricle. Strain and 
strain rate value was measured. From the assessment 
we got the value of strain are 4% in apicolateral and 
apicoseptal, -4% in midseptal and basal septal, -2% 
in midlateral, and -11% in basal lateral. With these 
result we concluded that there is dyskinetic in apical 
segment of the left ventricle (Figure 3). 
Figure 2. DSE result
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revascularization compared to medical management 
in patients with coronary disease and LV dysfunction 
is compatible with this hypothesis.6 The recoverable 
myocardium after revascularization has been called 
“hibernating”.7
Figure 3. Myocardial viability assessment using strain
Figure 4. The result of TC-99 Sestamibi myocardial perfusion scanning
Since many studies have established a relation 
between LV function and cardiovascular prognosis, it 
is reasonable to speculate that improved LV function 
following revascularization would be associated with 
a favorable effect on outcome. The superiority of 
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Figure 6. The anatomical segments in the 16 segmental model.8
Figure 5.(A) Death rates for patients with and without myocardial viability treated by revascularization or medical therapy. 
There is 79.6% reduction in mortality for patients with viability treated by revascularization (p <0.0001). In patients without 
myocardial viability, there was no significant difference in mortality with revascularization versus medical therapy. (B) Same 
data as (A) with comparisons based on treatment strategy in patients with and without viability. Annual mortality was 
lower in revascularized patients when viability was present versus absent (3.2% vs. 7.7%, p <0.0001). Annual mortality was 
significantly higher in medically treated patients when viability was present versus absent (16% vs. 6.2%, p <0.001).5
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This patient is diagnosed with chronic heart failure 
because of old anterior and inferior MCI with low 
ejection fraction. Assessment of myocardial viability 
is very important in this patient before he undergo 
revascularization either by CABG. This viability 
assessment is important to know the next management 
for this patient if CABG is still a good choice or 
conservative treatment with medical therapy is better 
than CABG. The decision can be made by assessing 
the number of viable segment in this patient. 
Dobutamine stress echo(DSE)
Several noninvasive approaches have been developed 
for the identification of myocardial viability in regions 
with contractile dysfunction due to coronary artery 
disease. The three most frequently proposed methods are 
based on the identification of very different physiologic 
markers: PET imaging assesses myocardial metabolic 
activity, typically using F-18 gluorodeoxyglucose as a 
marker of glucose utilization and N-13 ammonia for 
assessment of perfusion; Tl-SPECT assesses myocardial 
perfusion and membrane integrity; and dobutamine 
stress echocardiography (DSE) assesses myocardial 
contractile reserve (Figure 7).5
There are several specific indications for stress 
echocardiography as noted in the 2007 ASE stress echo-
cardiography guidelines. One of it is risk stratification 
for patients with known or suspected coronary artery 
disease. The presence and extent of ischemic, as well as 
dysfunctional but viable myocardium, can be evaluated.8 
Dobutamine echocardiography has emerged as the 
noninvasive clinical tool for the detection of hibernating 
myocardium. Dobutamine echocardiography examines 
the “inotropic reserve” of dysfunctional but viable 
myocardium by the administration of inotropic agents 
such as dobutamine, dopamine and isoproterenol. 
Dobutamine is generally safe and well tolerated by 
patients, including elderly adults and those also receiving 
atropine . However, both cardiac and noncardiac 
side effects can occur. Serious complications, such 
as ventricular fibrillation or myocardial infarction, 
occur in about 1 in 2000 studies.8 The 2002 ACC/
AHA guidelines identified absolute and relative 
cardiovascular contraindications to stress testing. 
Absolute contraindications include the following: acute 
myocardial infarction (within two days), unstable angina 
pectoris, uncontrolled arrhythmias causing symptoms 
of hemodynamic compromise, symptomatic severe 
valvular stenosis, uncontrolled symptomatic heart 
failure, active endocarditis or acute myocarditis or 
pericarditis, acute aortic dissection, acute pulmonary 
or systemic embolism, acute noncardiac disorders that 
may affect exercise performance or may be aggravated by 
exercise.9 Viable myocardium shows improved regional 
contractile function (inotropic reserve), as assessed 
by simultaneous transthoracic echocardiography, in 
response to these agents. The prevalence of contractile 
reserve in patients with CHD and LV dysfunction is 
independent of the angiographic extent and severity of 
coronary disease and the improvement in contractility 
in hypoperfused viable myocardium does not require an 
increase in regional myocardial perfusion.5
The improvement in regional or global LV 
function is a significant goal in such patients, the 
ability to accurately assess regional myocardial viability 
in a dysfunctional territory prior to revascularization 
becomes an important component of the decision 
making process. 
Dobutamine stress echocardiography protocole 
include stopping beta-blockers, calcium antagonists 
and nitrates in patients at least 2 days before DSE.After 
baseline echocardiography, dobutamine infusion was 
administered using a mechanical pump. Dobutamine 
was delivered intravenously beginning at 5 mikrogram/
kg/min for three minutes, Some protocole starts at 2,5 
mikrogram/kg/min increasing by 5 mikrogram/kg/min 
increments every three minutes until it reached 20 
mikrogram/kg/ min for an additional three minutes. 
Blood pressure was measured periodically, and the 
12-lead ECG was continuously monitored throughout 
Figure 7. Decrease in mortality with revascularization of 
viable myocardium for each testing technique shown as mean 
value with 95% confidence limits. Note wide confidence 
limits, especially for thallium and echocardiography. No 
measurable differences in test performance were observed. 
EF =ejection fraction; FDG=F-18 fluorodeoxyglucose.7
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the study and during the recovery phase. Grounds for 
termination of the infusion were a severe hypotensive 
or hypertensive response, significant arrhythmias, 
prolonged angina, significant electrocardiographic 
changes, appearance of new wall motion abnormalities 
in at least two segments, achievement of 85% of the 
maximum age-predicted heart rate, or completion of 
the protocol. Echocardiographic images were analyzed 
off-line and a 16-segment model was used, as suggested 
by the American Society of Echocardiography.10 The 
anatomical segments of the 16-segmental model are 
shown in Figure 6. Segmental wall motion at rest was 
scored on a four-point scale: (1) normal or mildly 
hypokinetic; (2) severely hypokinetic (decreased 
endocardial excursion and systolic wall thickening); (3) 
akinetic (absence of endocardial excursion and systolic 
wall thickening); and (4) dyskinetic or aneurysmal 
(paradoxical outward movement in systole).11
Demonstration of wall thickening in a previously 
akinetic segment or normalization of thickening in a 
previously hypokinetic segment were considered as 
criteria of myocardial viability. A dysfunctional left 
ventricular segment was considered to have contractile 
reserve if  infusion of dobutmine at 10 or 15 Ìg/kg/min 
resulted in an improvement in contractile function of 
at least one grade.
There are four different patterns were observed in 
the segments that were dysfunctional at baseline: (1) 
Biphasic response: improvement of wall motion during 
low dose (either at 5 or 10 mg) followed by worsening 
of wall motion during high dose dobutamine; (2) 
Sustained improvement: improvement at low or 
high dose dobutamine without deterioration of wall 
motion; (3) Worsening: deterioration of wall motion 
during either low or high dose dobutamine; (4) No 
change: absence of improvement or worsening during 
the entire test.8 
The predictive value to dobutamine echocar-
diography appears to be greatest when there is a 
biphasic response: improvement at low dose and 
worsening at high dose. The initial improvement in 
wall motion reflects recruitment of contractile reserve 
during low-dose dibutamine . In comparison, higher 
doses lead to subendocardial ischemia and worsening 
of the wall motion abnormality. Thus, testing at various 
doses appears to be needed for the optimal assessment 
of myocardial hibernation by this technique.
Dobutamine stress echocardiography showed a 
high sensitivity and specificity to predict improvement 
of regional LV function. The number of viable 
segments on DSE was linearly related to the magnitude 
of improvement of LVEF. The analysis showed that the 
cutoff value of four dysfunctional but viable segments 
(25% of the LV) yielded the highest sensitivity/
specificity to predict improvement of global LV 
function: 86% versus 90%. Patients with >4 viable 
segments showed improvement in heart failure 
symptoms and had a significantly lower event rate 
during 2-year follow-up (as compared with patients 
with, 4 viable segments on DSE).These findings 
imply that a substantial amount of viable myocardium 
needs to be present to establish improvement of global 
LV function after revascularization. Moreover, the 
magnitude of improvement of LVEF was linearly 
related to the number of viable segments on DSE. The 
presence of viable myocardium was linked not only to 
improvement of function, but also to improvement 
of heart failure symptoms. It has been demonstrated 
that the presence of substantial viability on DSE is 
associated with improvement in LVEF and heart failure 
symptoms after revascularization, and is accompanied 
by a favorable prognosis. Hence, viability testing by 
DSE may guide therapeutic management in patients 
with severely ischemic LV dysfunction.12
Patients who demonstrate myocardial viability 
with dobutamine echocardiography have a better 
outcome with revascularization than with medical 
therapy. In a study which evaluated 318 patients with 
coronary disease and a left ventricular ejection fraction 
≤35 percent, those with myocardial viability (as 
determined by dobutamine echocardiography) had a 
lower mortality at 18 months when treated with CABG 
compared to those with viability who were treated 
medically or those without viability who underwent 
CABG (6 versus 20 and 17 percent, respectively).13 
This patient has underwent dobutamine stress echo 
to asses the viability of the left ventricle and the test 
showed there is only viable myocardium in basal 
segment and the rest is non viable.  
DSE Vs other modalities
Combining DSE with either PET or Tl-SPECT 
allowed for stratification of asynergic segments into 
three subsets: (1) Segments found to be viable by 
both DSE and either of the scintigraphic techniques 
had the highest percentage of viable myocytes on 
histopathologic examination; (2) segments found to be 
nonviable by both DSE and a scintigraphic technique 
had the lowest percentage of viable myocytes; (3) 
Jurnal Kardiologi Indonesia  
104 Jurnal Kardiologi Indonesia •  Vol. 32, No. 2 • April - Juni 2011
segments that were viable by scintigraphy and had no 
contractile response with dobutamine had a percentage 
of viable cells intermediate.12
Thus, discrepancies among these methods appear 
to be primarily caused by the fact that dobutamine-
induced improvement of mechanical function 
depends on a greater percentage of viable myocytes 
than that required for demonstration of perfusion, 
cell integrity or metabolism by Tl-SPECT and PET. 
Dobutamine has been reported to be more specific for 
predicting functional recovery, while nuclear methods 
can detect smaller amounts of viable myocytes in 
asynergic myocardial regions. More importantly, that 
the combined use of echocardiography and nuclear 
methods may enhance our understanding about the 
degree of viability in a given segment and may offer 
information above and beyond simplistic classification 
as either viable or nonviable.14
It appears that a given segment has to contain at 
least approximately 50% viable myocytes to allow 
demonstration of contractile reserve, as evidenced by 
a positive dobutamine response. Comparison of the 
results presented here with previously reported clinical 
data make it likely that a similar percentage of viable 
myocytes may be required to allow functional recovery 
after revascularization and that functional recovery 
may be more accurately predicted by methods directly 
evaluating contractile reserve, such as DSE.14
However, scintigraphic methods that assess 
perfusion and/or metabolism appear also to identify 
segments with less than 50% or even less than 25% viable 
myocytes. Although revascularization of these segments 
may not contribute to a significant improvement of 
left ventricular systolic function, it may well provide 
clinical benefits by attenuating ventricular dilatation 
and remodeling, by reducing the risk of ventricular 
arrhythmias and by reducing the risk of subsequent 
fatal ischemic events. Dobutamine echocardiography 
and scintigraphic methods, therefore, may well provide 
complementary information in the assessment of 
myocardial viability. Current nuclear techniques 
appear to be highly sensitive for the detection of 
myocardial viability in asynergic myocardium, and 
negative tests make it highly unlikely that a significant 
number of viable myocytes are present in a given 
segment. Conversely, DSE  appears to be particularly 
useful for identifying segments with a greater number 
of viable myocytes and may, thus, have particular 
value for predicting recovery of systolic function after 
revascularization.14
The TC-99 Sestamibi myocardial perfusion 
scanning was done February 2010. Perfusion scanning 
showed fixed defect in anterior apical and apex (non 
viable), partial reversible defect in septum and inferior 
(viable) with stress LVEF 17% and rest LVEF 25%. 
Both the dobutamine stress echo and perfusion scanning 
showed the viable segment is less than 4 segment so 
the best management for this patient is conservative 
therapy with medical management. Viability assessment 
with dobutamine stress echocardiography and Thalium 
scanning is concordace to the literature. Perfusion 
scanning showed more viable segment in left ventricle 
compare to dobutamine stress echo. This is because 
perfusion scanning is more sensitive but less spesific 
than dobutamine stress echo. With this result then 
revascularisation either by CABG or PCI is not indicated 
and will increase the morbidity and mortality in this 
patient as showed by previous study. 
Recent and future developments
Doppler tissue imaging
Dobutamine stress two-dimensional echocardiography 
is an established method for the evaluation of patients 
with coronary artery disease. Although the present 
modality is clinically useful, a major limitation is the 
difficulty in deriving quantitative measures of regional 
wall motion and therefore the interpretation is mainly 
dependent on the ability of the operator. Recent 
advances in echocardiography have made it possible to 
measure directly the velocities of regional myocardium 
by use of Doppler tissue imaging (DTI), tissue velocity 
imaging and spekcle tracking. For the diagnosis of 
viable myocardium, Nishino, et al.15 firstly applied this 
technique to dobutamine stress echocardiography and 
demonstrated the usefulness of color DTI M-mode 
for the prediction of reversible dysfunction early 
after reperfusion in patients with acute myocardial 
infarction. Jun et al demonstrated that infarct segments 
with reversible dysfunction showed larger % S and 
smaller % PEP / ET than those without recovery, and 
% S ≥ 150% or % PEP / ET ≤ 100% may be useful 
criteria for the diagnosis of viable myocardium.16
Other modalities that can be use to assess myocardial 
viability is using tissue velocity and specle tracking. 
With these modalities we can count srain and strain rate 
deformation parameters to assess myocardial viability. 
Over the past 10 years, Color Doppler Myocardial 
Yansen I et al: Penilaian Viabilitas Miokardium dengan Dobutamine Stress Echo
105Jurnal Kardiologi Indonesia •   Vol. 32, No. 2 • April - Juni 2011
Imaging (CDMI) and more recently 2D-speckle 
tracking have evolved as new clinical and research tools 
to quantify regional myocardial function. This approach 
seems to offer substantial advantages over standard gray 
scale echocardiography. In this patient the value of strain 
concluded that there is dyskinetic in apical segment 
of left ventricle. The viability assessment using tissue 
doppler imaging, strain and strain rate value are now 
being study in large trial to prove that this modalities 
are usefull. Up till now there are no value of stain and 
strain rate that can be used to determine weather the 
segment is viable or non viable.
Myocardial contrast perfusion imaging
The onset of ischemic wall-motion abnormalities is 
preceded by development of regional disparities in 
coronary perfusion that can be assessed by contrast 
agents. Thus, use of contrast agents to assess myocardial 
perfusion during vasodilator stress may improve 
the sensitivity of stress echocardiography. Both 
real-time (low energy) and  triggered (high energy) 
imaging techniques have been shown to be useful for 
detection of coronary stenosis. The timing of contrast 
replenishment of a vascular bed has been found to be 
a useful indicator of the degree of coronary stenosis. 
Myocardial contrast perfusion imaging may have 
greater sensitivity than wall-motion analysis. However, 
the specificity of contrast perfusion imaging may be 
lower than for wall-motion analysis. 
The viability assessment using tissue doppler 
imaging, strain and strain rate echo, and myocardial 
contrast perfussion imaging are now being study in 
large trial to prove that this modalities are usefull . 
Preliminary study showed very promising fact that 
this modalities can be use to assess viability to reduce 
the limitation with the clasic dobutamine stress 
echocardiography.17
Summary
We have reported a case related to advanced heart 
failure because of old anterior and inferior MCI with 
low ejection fraction. It is very important to assess 
the viability in patients with advanced heart failure to 
know the future management because it is related to 
patient’s morbidity and mortality. Viability testing using 
dobutamine stress echo  showed that there is only little 
segments in the left ventricle that is still viable so the 
best management in this patient is conservative with 
medical therapy. Dobutamine stress echocardiography 
is one of the methods that can provide complementary 
information in the assessment of myocardial viability. 
Future modalities are now being studied to give more 
objective measurement of myocardial viability with 
higher sensitivity and specificity.
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